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ABSTRACT 
Background: Regular monitoring combined with early and appropriate use of airway clearance 
can reduce unplanned hospital admissions for patients with neuromuscular disease (NMD) and 
spinal cord injury (SCI). We aimed to describe and compare UK and Canadian knowledge of 
guidelines, monitoring of cough effectiveness, clinician prescription/provision of airway 
clearance strategies and service provision constraints.  
 
Methods: Cross sectional survey of clinicians affiliated with NMD and SCI clinics in Canada, 
Home Mechanical Ventilation UK 2016 meeting attendees, and UK physiotherapist networks. 
 
Results: We received 155 surveys (92 CAN; 63 UK). More UK (76%) than Canadian (56%) 
respondents were aware of airway clearance guidelines (P=0.02). Routine assessment of cough 
effectiveness was reported by more UK (59%) than Canadian (42%) respondents (P=0.04). Peak 
cough flow (PCF) was the most common method used in both countries though more commonly 
in the UK (96%) than Canada (81%, P=0.02). Fewer Canadian respondents reported using PCF 
before initiation of airway clearance (81% vs 94%, P=0.05), and showed results to patients for 
technique feedback (76% vs 97%, P=0.007). Similar participant numbers reported using PCF 
after initiation to ensure technique adequacy (73% vs 72%, P=0.92). 
 
Mechanical insufflation-exsufflation (MI-E) + lung volume recruitment (LVR) + manually 
assisted cough (MAC)) when PCF ≤270L/min was most routinely recommended (41% overall). 
Monotherapy was infrequent (LVR 15%, MAC 7%, and MI-E 4%). More Canadians identified 
service provision constraints, specifically insufficient public equipment funding (68% vs 39%, 
P=0.002) and inadequate community workers knowledge (56% vs 34%, P=.002). Funding for 
community support was a common constraint in both countries (49% vs 42%). 
 
Conclusions: The somewhat variable cough effectiveness monitoring and airway clearance 
practices identified in this survey confirms the need for further knowledge translation work 
related to guideline recommendations and the need to address common constraints to optimal 
service delivery. 
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Current Knowledge 
 
Decreased cough effectiveness causes respiratory complications for individuals with 
neuromuscular disorders (NMDs) and those with high spinal cord injury (SCI). Airway clearance 
techniques including lung volume recruitment, manually assisted cough, and mechanical 
insufflation-exsufflation devices augment cough effectiveness and promote secretion clearance. 
Therefore, monitoring and improvement of cough effectiveness are important goals in both 
ongoing management of NMD and SCI-rehabilitation. Professional society guidelines from both 
Canada and the UK make recommendations related to airway clearance, however uptake of these 
recommendations is unknown 
 
What This Paper Contributes To Our Knowledge 
Knowledge of guideline recommendations was moderate and adoption of practice 
recommendations related to cough effectiveness monitoring and airway clearance variable 
indicating the need for further knowledge translation work. Peak cough flow and qualitative 
assessment are the most common methods of determining cough effectiveness in both countries, 
yet routine assessment is not consistently practiced. Most commonly, multiple airway clearance 
strategies are used in combination. Constraints to optimal service delivery were frequent in both 
countries, with insufficient public funding of equipment and ability to provide support in the 
community common constraints 
  
6 
 
INTRODUCTION 
Decreased cough effectiveness is one of the main causes of respiratory complications such as 
atelectasis and pneumonia resulting in increased morbidity, mortality, and economic burden for 
individuals with neuromuscular disorders (NMDs) and those with high spinal cord injury (SCI). 
1-4 Cough is an important host defense mechanism for clearing the airway of secretions including 
those containing pathogenic organisms. 5 Interventions to augment cough effectiveness and 
promote secretion clearance include airway clearance techniques such as lung volume 
recruitment (LVR) (also termed breath-stacking), manually assisted cough (MAC), and 
mechanically assisted cough using a mechanical insufflation-exsufflation (MI-E) device. The 
increased lung volumes generated via LVR improve elastic recoil thereby increasing peak cough 
flow and promoting sputum expectoration. 5 Manually assisted cough further enhances peak 
cough flow for patients with weak expiratory muscles such as those with NMD or SCI. 6 MI-E 
produces enhanced peak cough flows (PCF) when compared with manual techniques. 7  
 
Monitoring and improvement of cough effectiveness are important goals in both ongoing 
management of NMD and SCI-rehabilitation. 8 For individuals experiencing progressive NMD, 
regular assessment of pulmonary function including PCF is important for detection of 
deterioration of cough effectiveness and the need for airway clearance interventions. 9 Failure to 
monitor cough effectiveness and implement airway clearance interventions result in increased 
emergency department visits, hospital admissions, need for invasive mechanical ventilation, and 
decreased survival as a result of premature death. 10, 11 Professional society guidelines from both 
Canada and the UK make recommendations related to airway clearance. 11-14 However, some 
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data suggest that use of airway clearance interventions is variable15 with anecdotal evidence 
indicating use is not always based on systematic monitoring of PCF. 
 
Our overall goal was to understand uptake of guideline recommendations related to monitoring 
of cough effectiveness and utilization of airway clearance strategies in Canada and the UK to 
inform the need for knowledge translation strategies. Therefore, we sought to describe and make 
UK and Canadian comparisons of: (1) awareness of guideline recommendations and current 
practice related to monitoring cough effectiveness; and (2) clinician prescribing and 
recommendations for use of airway clearance strategies. Secondary objectives were to identify 
current education for patients and families related to use of airway clearance techniques, and to 
understand existing constraints to service provision barriers particularly in terms of guideline 
recommendations. 
 
METHODS 
Study Design and Sample  
We conducted a cross-sectional survey of respiratory & physio-therapists, respiratory medical 
specialists, nurses, physiatrists, and neurologists working with clinics participating in the 
Canadian Neuromuscular Disease Registry (CNDR) and the Rick Hansen Spinal Cord Injury 
Registry (RHSCIR), members of the Canadian Neuromuscular Disease Network (CAN-NMD) 
from Nov 2016 to Feb 2017, and 119 delegates of the Home Mechanical Ventilation (HMV) UK 
June 2016 meeting as well as UK physiotherapist networks including the Specialists in Long-
term Ventilation at Home network. The CNDR and the RHSCIR are pan-Canadian registries 
with sites located at 23 NMD clinics and 31 acute care and rehabilitation facilities treating SCI 
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patients. The CAN-NMD is a national network of over 170 researchers, clinicians, and educators 
working with patients with NMD.  
 
Survey Development 
Our interprofessional investigator team comprising clinicians and researchers from medicine, 
nursing, respiratory therapy, and physiotherapy with expertise in airway clearance techniques, 
NMD, and SCI, iteratively generated survey items under the domains of provider knowledge, 
current practice, patient/family education, and constraints to service provision. We iteratively 
reduced items based on face and content validity to enable the production of a concise survey 
without removing domains or questions deemed important to the survey objectives.  
 
Survey Pre-testing  
Eleven experts in airway clearance techniques, home ventilation, and survey methodology 
reviewed the survey and rated the instrument’s clarity, content validity, and comprehensiveness. 
16 Experts were asked to comment on the relevance of each item; omission of important 
questions; ease of understanding; and presence of inappropriate or redundant items. The survey 
instrument was refined and then re-evaluated by the expert panel until no further issues were 
identified.  
 
Survey Pilot Testing  
The survey instrument was pilot tested with five international experts not involved in the 
instrument develop phases, who provided comment on the overall face and content validity as 
well as completion time. 
9 
 
 
 
Survey administration 
Prior to the survey, administrators of the various networks and membership lists of our sample 
frame sent an advance notice to foster engagement. Due to privacy laws around membership 
lists, these same administrators then sent the survey via email containing a link to the online 
survey hosted on SurveyMonkey. We provided slightly modified versions of the survey 
(Supplementary material) for participants known to be working with SCI patients and for UK 
participants. Participants were encouraged to forward the link to eligible colleagues. To 
maximize the response rate, email reminders were sent at two weeks and one month after the 
initial invitation. Survey respondents were asked to confirm their eligibility i.e., practice that 
includes monitoring and management of patients with NMD at risk of respiratory failure, and/or 
individuals with NMD or SCI currently requiring non-invasive or invasive ventilation in the 
home, at the beginning of the survey.  
 
Data analysis  
We used descriptive statistics, including means and standard deviations or medians and 
interquartile ranges depending on data distribution for continuous variables, and frequencies, 
proportions for categorical variables. We compared categorical responses between UK and 
Canadian respondents using chi square tests. We carried out analyses using SAS 9.3 (SAS 
Institute, Cary, NC). All analyses were two tailed with a p-value ≤0.05 considered statistically 
significant. 
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Ethical Considerations 
We obtained relevant Research Ethics Board approvals for the study. Return of survey was 
considered indicative of informed consent.  
 
RESULTS 
Participants and Service Volume 
We received 155 surveys; 92 from Canada and 63 from the UK. Due to an unknown 
denominator because of our multiple and snowballing survey distribution, we were unable to 
calculate an overall survey response rate. Canadian respondents comprised 30 (34%) respiratory 
therapists, 24 (27%) physiotherapists, 9 (10%) nurses, 14 (16%) respiratory medical specialists, 6 
(7%) neurologists, and 6 (7%) other (4 physiatrists, 1 intensivist, 1 pediatrician). UK respondents 
comprised 31 (49%) respiratory physiotherapists, 18 (29%) nurses, 10 (16%) respiratory medical 
specialists, and 4 (6%) other (2 intensivists, 1 occupational therapist and 1 respiratory 
physiologist). Most Canadian (50, 54%) respondents had over 10 years of experience working 
with our patient population of interest, whereas most UK (44, 70%) respondents had over 5 years 
of experience. In both countries, respondents represented most regions (Table 1). 
 
There was variation in both Canada and the UK in terms of clinic or program size the 
participants represented, the number of patients commenced on MI-E and the number 
commenced on non-invasive ventilation (NIV) on an annual basis (Table 2). 
 
Knowledge of Guidelines  
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More UK (76%) than Canadian (56%) respondents were aware of any published guidelines with 
recommendations for monitoring of cough effectiveness and commencement of airway clearance 
interventions (P=0.02). Of the UK participants aware of guidelines, 98% identified that PCF was 
recommended for monitoring cough effectiveness; 90% of Canadian participants aware of 
guidelines identified PCF as the test recommended.  
 
Current Practice 
More UK (59%) than Canadian (42%) respondents (P=0.04) reported routine assessment of 
cough strength adequacy as their current practice. The most frequent method to assess cough 
effectiveness in both countries was PCF though used more commonly in the UK (96%) than 
Canada (81%, P=0.02). Other common methods were qualitative assessment of cough 
effectiveness (44% vs 44%), and maximal inspiratory pressure/maximal expiratory pressure 
(MIP/MEP) (31% vs 44%) with no between country differences for use of these two methods 
(Table 3).  
 
More UK (94%) than Canadian (81%) respondents reported measuring PCF before initiation of 
airway clearance (P=0.05), and showed the results to patients to enable feedback on their airway 
clearance technique (97% vs 76% vs, P=.007). Thirteen (19%) Canadian respondents indicated 
PCF was never measured. Reasons were no access to PCF equipment (7/13, 69%), using other 
measures (4/13, 31%), unfamiliar with PCF measurement (3/13, 23%), and not perceiving PCF 
to be useful to guide treatment (4/13, 31%).  Prescribing of airway clearance strategies was based 
primarily on PCF results in the UK whereas worsening symptoms (50%) was the most common 
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reason for commencing therapy in Canada. Similar proportions of respondents in both countries 
measured PCF after initiation to ensure technique adequacy (73% vs 72%, P=0.92). 
 
A combination including all three  airway clearance techniques i.e., LVR +/- MAC + MI-E if 
PCF <270 L/min when the PCF ≤270 L/min was the airway clearance strategy most routinely 
recommended on initiation (41% overall, 54% UK and 32% Canadian). Single therapy was 
infrequent (LVR 15%, MAC 7%, and MI-E 4% in both countries). Most commonly prescribed 
minimum frequency of airway clearance in both countries was 2 to 3 times each day. More UK 
than Canadian participants indicated presence of a standardized plan or guideline for monitoring 
of cough strength and initiation of airway clearance techniques in their clinic or program. (60% 
vs 38%, P=0.02). 
 
Of the UK respondents, 82% indicated their practice included always recommending or 
prescribing airway clearance techniques when considered appropriate, whereas only 55% of 
Canadian respondents described such practice. Fifteen per cent of UK and 29% of Canadian 
respondents indicated that they only sometimes recommended airway clearance techniques with 
main reasons being: anticipated non-adherence, inability to provide ongoing support or 
education, unable to access equipment for all patients, insufficient evidence of effectiveness for 
some patient groups, and impaired bulbar function. Referral to another clinic or specialist was 
the reason why 10 respondents (2 UK and 8 Canadian) never recommended airway clearance 
strategies. 
 
Education for Patient and Families 
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All UK and Canadian respondents indicated initial teaching on airway clearance techniques was 
provided either all (UK 91%, Canada 26%) or some (UK 9%, Canada 74%) of the time in their 
clinic or program, most commonly by physio (UK) and respiratory (Canada) therapists. Of the 
UK respondents, 59% reported initial teaching was provided in the home in addition to clinic 
teaching; ongoing support and trouble shooting at home was provided by 69%. Ability to 
conduct initial teaching (29%) and deliver ongoing support (39%) in the home was less frequent 
among Canadian respondents. 
 
Constraints to Service Provision 
More Canadians identified constraints to service provision, specifically insufficient public 
funding of equipment (68% vs 39%, P=0.002) and inadequate knowledge of community workers 
(56% vs 34%, P=0.02). Funding for support and trouble-shooting in the home was a common 
constraint in both countries (49% vs 42%) (Figure 1). 
 
DISCUSSION 
In this self-report survey of clinicians representing the range of professions involved in 
respiratory management of NMD and SCI, we found awareness of professional society guideline 
recommendations related to airway clearance was more common among UK than Canadian 
clinicians. Routine assessment of cough strength and use of PCF to guide initiation of airway 
clearance, as recommended in guidelines, was also more common among UK clinicians. 
Frequently cited reasons for not using PCF by Canadian respondents related to lack of access to 
necessary equipment, and use of other measures to guide therapy. Multiple airway clearance 
techniques, two to three times per day, was the most common airway clearance prescription in 
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both countries. More Canadian respondents reported constraints in service delivery, particularly 
insufficient public funding for equipment, and insufficient knowledge of airway clearance 
techniques by community health care providers. Interestingly, despite 69% of UK respondents 
indicating they provided ongoing support and trouble shooting in the home, lack of funding and 
inability to provide this type of support were the most frequently reported service constraints by 
UK respondents. 
 
We found moderate awareness of guideline recommendations for monitoring of cough 
effectiveness and commencement of airway clearance interventions. Lack of awareness of 
guideline recommendations is an obvious barrier to their uptake.17 Pertinent guidelines were 
published more than five years12, 14 before conduct of our survey, which arguably should be 
sufficient time for widespread dissemination. As members of the Canadian Thoracic Society 
Home Ventilation guidelines are on this research team, we are aware that dissemination however 
was primarily passive i.e., professional society endorsement, conference presentation, and peer-
reviewed publication. We cannot comment on the processes used to disseminate the UK 
guidelines.  UK and Canadian differences in routine measurement of cough strength adequacy 
and use of PCF to guide initiation of airway clearance strategies may be attributable to 
differences in guideline awareness. Additional reasons may be Canadian reported constraints to 
use of PCF such as no access to required equipment, although we cannot confirm if this refers to 
lack of access to portable peak flow meters or to more sophisticated pulmonary function testing, 
and the perception that PCF was not useful in guiding treatment decisions. Alternatively, 
differences between countries may be attributable to differences in our survey sample frame as 
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attendees of the UK Home Ventilation conference may be more invested in delivery of airway 
clearance interventions. 
 
Among Canadian respondents, the most common constraint to ideal service provision was public 
funding of equipment. In Canada, a country comprising ten provinces and three territories and a 
population of 35 milllion,18 most healthcare is funded through general taxation, however public 
funding of assistive devices such as MI-E is highly variable and province specific. For example, 
in Ontario, the most populous province, the provincial government funded provision of MI-E 
from April 2014 (personal communication, Regina Pizzuti, Ventilator Equipment Pool). In 
British Columbia, publicly funded equipment for LVR is available through the Provincial 
Respiratory Outreach Program (PROP); access to MI-E for adults is limited and provided on a 
priority basis. In Alberta, there is no public funding of MI-E devices. In the UK, specialist 
centres may be contracted by their Clinical Commissioning Group (CCG), a clinically-led 
statutory National Health Service (NHS) body responsible for commissioning of health care 
services for their local area, to provide equipment for airway clearance. 19 Other providers may 
apply for public funding of equipment for an individual based on assessed need with a written 
application to their CCG, which may or may not be approved. We included the UK and Canada 
in this study due to relative similarities in terms of publicly funded universal healthcare and 
publication of professional society guidelines with clear guidance on airway clearance. We did 
not include participants from the US due to substantial differences in provision of healthcare. 
However, our findings related to common practices in relation to assessment of cough strength 
and use of cough augmentation strategies, may be similar in the US and warrants investigation. 
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Other common constraints to ideal service provision were knowledge of community healthcare 
providers regarding airway clearance techniques and the ability to provide support and follow up 
in the home. Again, in both countries these aspects of care delivery are highly variable based on 
proximity to a specialist centre and regional variation in service delivery models.20 In our 
previous national Canadian study of 152 (113 local community, 38 institutional) home 
ventilation providers,15 58% indicated they were able to provide some form of follow-up in the 
home and only 41% indicated they provided training to community healthcare providers external 
to their institution. Although not specific to airway clearance, data from a qualitative interview 
study of 33 individuals receiving home ventilation and their family caregivers, also identified 
need for home outreach and increased training of community healthcare providers as potential 
facilitators to transition to HMV. 21  
 
Study strengths and limitations 
Strengths of our study include the rigorous survey development process and data reflecting 
practice across two geographical regions. As with any self-report survey, our findings may 
reflect social desirability bias and are subject to selection bias. However, a strength of our data is 
that those providing direct patient care, i.e. respiratory therapists and physiotherapists were well 
represented among survey participants. Differences in the sampling frame in the two countries 
may have resulted in the identified differences in guideline awareness and clinical practices. 
Furthermore, our findings may not be generalizable to clinicians managing patients outside of 
specialist NMD, SCI, or HMV clinics or centres who were likely not accessed through our 
sampling strategies. 
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CONCLUSION 
In this self-report survey of clinicians in Canada and the UK providing care to patients requiring 
assistance with airway clearance, we found moderate awareness of guideline recommendations 
related to cough effectiveness monitoring. Awareness and practice adhering to guideline 
recommendations was more common among UK respondents, but this may be reflective of the 
sample frame. Although PCF was the most common test assessed in both countries, a wide range 
of other tests were used including qualitative assessment, which may not be the most optimal 
method to guide therapy. More Canadians reported constraints in service delivery although 
insufficient public funding for equipment and inability to provide support in the home were 
common constraints in both countries. The somewhat variable cough effectiveness monitoring 
and airway clearance practices for NMD and SCI patents identified in this survey confirms the 
need for further knowledge translation work related to guideline recommendations and the need 
to address common constraints to optimal service delivery. 
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Figure 1 Legend:  
Constraints to service provision 
 
